Market Cap : 2.88 B | Enterprise Value : 3.4 B | PE Ratio : 14.29 | PB Ratio : 2.75 |
---|
NAS:PDCO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:PDCO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Patterson's enterprise value is $3,396 Mil. Patterson's EBITDA for the trailing twelve months (TTM) ended in Apr. 2022 was $369 Mil. Therefore, Patterson's EV-to-EBITDA for today is 9.21.
The historical rank and industry rank for Patterson's EV-to-EBITDA or its related term are showing as below:
During the past 13 years, the highest EV-to-EBITDA of Patterson was 18.42. The lowest was -10.61. And the median was 11.50.
PDCO's EV-to-EBITDA is ranked worse thanEV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2022-08-17), Patterson's stock price is $29.55. Patterson's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2022 was $2.070. Therefore, Patterson's PE Ratio for today is 14.28.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
The historical data trend for Patterson's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Patterson's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Distribution industry and Healthcare sector, Patterson's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Patterson's EV-to-EBITDA falls into.
Patterson's EV-to-EBITDA for today is calculated as:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA (TTM) |
= | 3395.527 | / | 368.534 | |
= | 9.21 |
Patterson's current Enterprise Value is $3,396 Mil.
Patterson's EBITDA for the trailing twelve months (TTM) ended in Apr. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $369 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Patterson's PE Ratio for today is calculated as:
PE Ratio | = | Share Price (Today) | / | Earnings per Share (Diluted) (TTM) |
= | 29.55 | / | 2.070 | |
= | 14.28 |
Patterson's share price for today is $29.55.
Patterson's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.070.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Please read Which price ratio outperforms the enterprise multiple?
Thank you for viewing the detailed overview of Patterson's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Mckoy Philip | director | 120 BROADWAY SUITE 200 SANTA MONICA CA 90401 |
Rogan Timothy E | officer: President - Dental | 1031 MENDOTA HEIGHTS ROAD ST. PAUL MN 55120 |
Shirley Eric R | officer: President-Patterson Dental | 1031 MENDOTA HEIGHTS ROAD ST. PAUL MN 55120 |
Zurbay Donald | officer: Chief Financial Officer | C/O ST. JUDE MEDICAL, INC. ONE ST JUDE MEDICAL DRIVE ST. PAUL MN 55117 |
Malecha Francis Joseph | director | 9900 WEST 109TH STREET, SUITE 100 OVERLAND PARK KS 66210 |
Frohning Andrea L. | officer: Chief Human Resources Officer | 13515 BALLANTYNE CORPORATE PLACE CHARLOTTE NC 28277 |
Frenzel Robert | director | 414 NICOLLET MALL MINNEAPOLIS MN 55401 |
Goedken Dennis W | officer: Interim CFO | 1031 MENDOTA HEIGHTS ROAD ST. PAUL MN 55120 |
Walchirk Mark S | director, officer: President & CEO | 1031 MENDOTA HEIGHTS ROAD ST. PAUL MN 55120 |
Pohlman Kevin M | officer: President - Animal Health | 822 7TH STREET, SUITE 740 GREELEY CO 80631 |
Blanco Alex N | director | ONE BAXTER PARKWAY DEERFIELD IL 60015 |
Misiak David G | officer: President, Patterson Dental | 1031 MENDOTA HEIGHTS ROAD ST. PAUL MN 55120 |
Baker Kelly A | officer: CHRO | 1031 MENDOTA HEIGHTS ST. PAUL MN 55120 |
Korsh Les B | officer: VP, General Counsel | 1031 MENDOTA HEIGHTS ROAD ST. PAUL MN 55110 |
Adent John Edward | officer: CEO - Subsidiary | 822 7TH STREET, SUITE 740 GREELEY CO 80631 |
From GuruFocus
Other Sources
By Zacks 2022-03-22
By Zacks 2022-01-11
By Zacks 2022-01-14
By Zacks 2022-01-11
By Zacks 2022-01-13
By Zacks 2022-03-17
By Zacks 2022-01-14
By Zacks 2022-02-24
By Zacks 2022-02-23
By Zacks 2022-02-28
By Zacks 2022-01-05
By Zacks 2021-12-27
By Seekingalpha 2022-03-02